Background. Anaesthetic steroids are established positive allosteric modulators of GABA A receptors, but little is known concerning steroid modulation of strychnine-sensitive glycine receptors, the principal mediators of fast, inhibitory neurotransmission in the brain stem and spinal cord. This study compared the modulatory actions of ®ve anaesthetic pregnane steroids and two non-anaesthetic isomers at human recombinant a 1 glycine and a 1 b 2 g 2L GABA A receptors.
propofol, etomidate and numerous inhalational agents. 3±5 Moreover, recent studies using mice genetically engineered to express select GABA A receptor isoforms insensitive to the intravenous agent etomidate have demonstrated that suppression of the nocifensive re¯ex, or sedation, in response to this anaesthetic are associated with the modulation of b 3 -and b 2 -subunit-containing GABA A receptors, respectively. 6 7 In common with the GABA A receptor, in vitro studies have demonstrated that the glycine receptor is subject to positive allosteric regulation by select anaesthetic agents including; propofol, trichloroethanol and volatile halogenated hydrocarbons. 2±5 However, there is no in vivo evidence that ®rmly establishes the glycine receptor as a target of intravenous anaesthetic action, although evidence exists that immobility induced by halothane is, at least in Fig 1 Chemical structures of the steroid compounds examined in this study. By convention, substituents projecting below (broken wedges) and above (solid wedges) the plane of the steroid ring system are in the a and b con®gurations, respectively. The orientation of the C5-hydrogen in the saturated ring systems determines the con®guration of the A and B ring fusion (5a-pregnane series, trans; 5b-pregnane series, cis). Steroids with anaesthetic activity are: alphaxalone, Org 20599, minaxolone, 5a-pregnan-3a-ol-20-one and 5b-pregnan-3a-ol-20-one (eltanolone).
part, mediated by glycine receptors. 8 To further evaluate a potential role of the glycine receptor in anaesthesia, the present study has examined the activity of anaesthetic and non-anaesthetic steroids at recombinant GABA A (a 1 b 2 g 2L ) and glycine (a 1 ) receptors. Steroidal agents are of particular interest due both to their remarkable potency as modulators of GABA A receptor activity and exquisite stereoselectivity of action in vitro and in vivo. 3 In addition, the amidine steroid, RU 5135, is a potent antagonist of GABA A and glycine receptors, 9 10 suggesting that potential steroid binding sites exist on both receptor types. Speci®cally, we have examined the activity of ®ve anaesthetic pregnane steroids (alphaxalone, minaxolone, ORG 20599, 5b-pregnan3a-ol-20-one (eltanolone) and 5a-pregnan-3a-ol-20-one), two non-anaesthetic epimers (5a-pregnan-3b-ol-20-one and 5b-pregnan-3b-ol-20-one) and three glucocorticosteroids previously suggested to be positive allosteric modulators of glycine receptor activity 11 (see Fig. 1 for chemical structures).
Methods
Expression of GABA A and glycine receptor subunits in Xenopus laevis oocytes Xenopus laevis oocytes (Stage V±VI) were defolliculated by pre-treatment with 2 mg ml ±1 collagenase type I (SigmaAldrich) for 2±3 h at room temperature (20±23°C) in Barth's saline with Ca 2+ salts omitted. cDNAs encoding the glycine receptor a 1 subunit, were injected intranuclearly (20 nl of 2.0 mg ml ±1 ) whereas cRNAs encoding GABA A receptor a 1 , b 2 and g 2L subunits were injected into the cytoplasm (30±50 nl of 1 mg ml ±1 for each subunit). Oocytes were subsequently maintained at 19±20°C for 2 to 12 days in 96-well plates containing 200 ml of standard Barth's solution (composition in mM: NaCl 88, KCl 1, NaHCO 3 2.4, Hepes (N-[2-hydroxyethyl]piperazine-N¢-[2-ethane-sulphonic acid]) 15, Ca(NO 3 ) 2 0.5, CaCl 2 0.5 and MgSO 4 1.0; adjusted to pH 7.6 with NaOH). The solution was supplemented with 0.1 mg ml ±1 gentamicin.
Electrophysiological recordings
Oocytes were held in a recording chamber (0.5 ml) and continuously superfused (7±10 ml min ±1 ) with frog Ringer solution (composition in mM: NaCl 120, KCl 2, CaCl 2 1.8, Hepes 5; adjusted to pH 7.4 with NaOH). Oocytes were voltage-clamped at a holding potential of ±60 mV using a Gene Clamp 500 ampli®er (Axon Instruments, Foster City, USA) in the two-electrode voltage clamp mode. Voltagesensing and current-passing electrodes were ®lled with 3 M KCl and had resistances of 1±2 MW when measured in frog Ringer solution. Current and voltage signals were both acquired (at the digitization rate of 100 Hz) and analysed with the Win WCP program (courtesy of Dr J. Dempster, University of Strathclyde, UK; http://www.strath.ac.uk/ Departments/PhysPharm/), utilizing a Dell Dimension Pentium PC and an Axon Instruments 1200 Digidata interface A to D converter. Timed pulses of drugs dissolved in Ringer solution were applied to oocytes via a BPS-4 bath perfusion system (Adams and List Associates, New York, USA) with a four-way manifold. For each oocyte a maximally effective concentration of GABA (3 mM) or glycine (1 mM) was applied once every 20 min until the peak inward current response produced was stable. 12 In the majority of experiments investigating potentiation by steroids, a concentration of GABA, or glycine, which produced a response 10% of the maximal agonist-evoked response (EC 10 ) was utilized. The EC 10 was determined for each oocyte. The steroid was pre-applied for 30 to 60 s before coapplication with the appropriate concentration of GABA, or glycine. Concentration±response data for the enhancement of agonist-evoked responses by steroids were ®tted iteratively by use of SigmaPlot version 8.01 (SPSS Inc., Chicago, IL, USA), with the four-parameter Hill equation:
where I m is the amplitude of the agonist-evoked current in the presence of the steroid at concentration [A], I m(max) is the amplitude of the response in the presence of a maximally effective concentration of the steroid, I c is the amplitude of the agonist-evoked response in the absence of the steroid, EC 50 is the concentration of the steroid producing halfmaximal enhancement and nH is the Hill coef®cient. In all instances, the amplitude of the modulated current is expressed as a percentage of the control agonist-evoked current (I c ) recorded in the absence of steroid. In instances where the concentration±response relationship for agonist modulation was clearly bell-shaped, curve ®tting was restricted to the ascending limb and apparent maximum. Quantitative results are expressed as the arithmetic mean (SEM) (standard error of the mean).
Reagents g-aminobutyric acid (GABA), glycine, 5a-pregnan-3a-ol-20-one, 5b-pregnan-3a-ol-20-one, 5a-pregnan-3b-ol-20-one, 5b-pregnan-3b-ol-20-one, 20a-dihydrocortisol, a-cortol and hydrocortisone were purchased from Sigma-Aldrich (Poole, Dorset, UK). Alphaxalone and minaxolone were donated by Glaxo-Smith-Kline (Stevenage, Hertfordshire, UK). Org 20599 [(2b,3a,5b)-21-chloro-3-hydroxy-2-(4-morpholinyl)-pregnan-20-one] was provided by Organon Laboratories (Newhouse, Lanarkshire, UK). Steroidal agents (with the exception of Org 20599 and minaxolone) were initially dissolved as concentrated stock solutions in dimethylsulphoxide (DMSO) and subsequently diluted to the desired concentration in frog Ringer solution. In vehicle controls, the highest ®nal concentration of DMSO employed (0.1% vol vol ±1 ) had no effect upon current responses to either GABA, or glycine. All other agents were dissolved as concentrated stock solutions in double distilled deionized water. Stock solutions of all compounds were prepared daily.
Results
Modulation of glycine and GABA A receptor activity by alphaxalone, Org 20599 and minaxolone
Within the concentration range 1±100 mM, alphaxalone, minaxolone and Org 20599 all produced a concentrationdependent enhancement of the peak inward current evoked by glycine at EC 10 acting upon homo-oligomeric, strychnine-sensitive, glycine receptors expressed in Xenopus laevis oocytes. Over the range of concentrations examined, the anaesthetics did not elicit a detectable current response when applied in the absence of glycine. The EC 50 values for potentiation of the response to glycine by alphaxalone ( Fig. 2A ) and Org 20599 ( Fig. 2B ) were 27.8 (5.8) mM (n=4) and 22.9 (1.5) mM (n=3) respectively, whereas that for minaxolone was 13.1 (0.9) mM (n=4, Table 1 , Fig. 2C) . At the highest concentration tested (100 mM), the rank order in which the steroids increased the amplitude of the glycineevoked current (expressed as a percentage of control) was minaxolone (1197 (134)%, n=4) >Org 20599 (535 (81)%, n=3) >alphaxalone (199 (14)%, n=4, Table 1 ). Both the potency and maximal effect of alphaxalone and Org 20599 at the glycine receptor were substantially less than previously reported for positive allosteric modulation of GABA A receptors assembled from the a 1 b 2 g 2L subunit combination. 13 In contrast, in the present study, although minaxolone was approximately 10-fold more potent (EC 50 =1.3 (0.2) mM, n=3) in potentiating currents evoked by GABA at EC 10 acting upon the GABA A receptor, the maximal potentiation (to 901 (142)% of control) was less than that found for the glycine receptor (Fig. 2C) . The modulatory effects of the steroids at glycine and GABA A receptors are summarized in Table 1 .
Modulation of glycine and GABA A receptor activity by 5b-pregnan-3a-ol-20-one (eltanolone) and its stereoisomers
In preliminary experiments 5b-pregnan-3a-ol-20-one produced a concentration-dependent inhibition of the response to glycine at EC 10 . To quantify this effect with greater precision, all subsequent experiments using pregnane steroid isomers were conducted using an EC 50 concentration of glycine. 5b-pregnan-3a-ol-20-one blocked the response to glycine in a concentration-dependent manner (Fig. 3) . The threshold for inhibition was approximately 300 nM and at the highest concentration of the steroid tested (10 mM), the glycine-evoked response was reduced to 57 (4)% (n=6) of control (Fig. 3 ). Higher concentrations of the steroid, that would allow the calculation of an unambiguous IC 50 value, Table 1 for ®tted parameters). All recordings and data were obtained from oocytes voltage-clamped at ±60 mV. The data for the modulation of GABA A a 1 b 2 g 2L receptors by Org 20599 and alphaxalone are derived from Hill-Venning et al. (1996) 13 and are shown for comparison.
could not be tested due to the limited solubility of the compound. This inhibitory action contrasts with a modest potentiation observed for the 5a-isomer, 5a-pregnan-3a-ol-20-one which, at a concentration of 10 mM, enhanced the glycine-evoked current to 133 (7)% (n=7) of control with an EC 50 of 250 (190) nM (Fig. 3) . In contrast to compounds with the 3a-ol con®guration, neither 5a-pregan-3b-ol-20-one, nor 5b-pregnan-3b-ol-20-one (10 nM±10 mM, each n=3), had any effect upon glycine-evoked currents (Fig. 3) . For comparative purposes, we examined the effect of 5b-pregnan-3a-ol-20-one, 5a-pregnan-3b-ol-20-one and 5b-pregnan-3b-ol-20-one upon a 1 b 2 g 2L GABA A receptors, having reported upon 5a-pregnan-3a-ol-20-one previously.
14 5b-pregnan-3a-ol-20-one (10 nM±10 mM) increased the response to GABA at EC 10 with an EC 50 of 262 (74) nM and a maximal enhancement to 722 (54)% of control in the presence of the steroid at a concentration of 1 mM. Concentrations of 5b-pregnan-3a-ol-20-one in excess of 1 mM were associated with a reduced potentiation, producing a bell-shaped concentration±response curve. Over the same concentration range, neither 5a-pregnan3b-ol-20-one, nor 5b-pregnan-3b-ol-20-one, had any signi®cant effect upon the response to GABA (Fig. 4) , consistent with data previously obtained for native GABA A receptors. of bath applied 5a-pregnan-3a-ol-20-one, 5b-pregnan-3a-ol-20-one, 5a-pregnan-3b-ol-20-one and 5b-pregnan-3b-ol-20-one and the current produced by glycine plotted on a linear scale and expressed as a percentage of the control response in the absence of steroid. Each data point is the mean (SEM) of the results obtained from 3±7 oocytes (see Table 1 for ®tted parameters). All recordings and data were obtained from oocytes voltage-clamped at ±60 mV.
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1 Modulation of a 1 glycine receptors and a 1 b 2 g 2L GABA A receptors by steroid anaesthetics. Data are quanti®ed as the mean (SEM) of the data from 3±7 experiments. Abbreviations: 5a3a, 5a-pregnan-3a-ol-20-one; 5b3a, 5b-pregnan-3a-ol-20-one; ND=not determined 1 Glycine receptors a
Fig 4
Modulation of recombinant GABA (a 1 b 2 g 2L ) receptors expressed in Xenopus laevis oocytes by pregnane steroid diastereomers. The graph illustrates the relationship between the concentration (logarithmic scale) of bath applied 5a-pregnan-3a-ol-20-one, 5b-pregnan-3a-ol-20-one, 5a-pregnan-3b-ol-20-one and 5b-pregnan-3b-ol-20-one and the current produced by GABA plotted on a linear scale and expressed as a percentage of the control response in the absence of steroid. Each data point is the mean (SEM) of the results obtained from 3±4 oocytes (see Table 1 for ®tted parameters). All recordings and data were obtained from oocytes voltage-clamped at ±60 mV. The data for 5a-pregnan-3a-ol-20-one are derived from Belelli et al. (2002) 14 and are shown for comparative purposes.
The in¯uence of glucocorticosteroids on the glycine receptor
It has been reported that 20a-dihydrocortisol, a-cortol and hydrocortisone potentiate the depolarizing response to glycine recorded extracellularly from the rat optic nerve in vitro. 11 In the present study, each of these steroids was examined over the concentration range 300 nM±30 mM for their effect upon homo-oligomeric glycine receptors activated by glycine at EC 10 . No signi®cant effect was detected for any of the compounds examined (n=3 in each case, data not shown).
Discussion
The major ®ndings of the present study are ®rstly that minaxolone is an effective positive allosteric modulator of the a 1 glycine receptor and secondly that modulation of glycine receptor activity by 5a-pregnan-3a-ol-20-one and 5b-pregnan-3a-ol-20-one demonstrates an inverse relationship, the former eliciting modest potentiation and the latter producing inhibition.
Minaxolone has previously been shown to enhance the displacement by glycine of [ 3 H]strychnine bound to glycine receptors in synaptosomal membranes of rat spinal cord, 18 a ®nding congruent with the positive allosteric regulation demonstrated in the present study. The activity of minaxolone is notable because the maximal effect of the steroid to potentiate currents mediated by the a 1 -glycine receptor was comparable to that observed for GABA A receptors assembled from a 1 , b 2 and g 2L subunits. Similarly, the second water-soluble steroid examined, Org 20599, also exhibited considerable activity at the glycine receptor. Although some steroids, including alphaxalone, 19 pregnenolone 20 and pregnenolone acetate, 20 have previously been shown to potentiate responses to glycine mediated by the a 1 receptor, their maximal effects in comparison to either minaxolone, or Org 20599, are relatively weak. A limited ability of high concentrations (i.e. 30±100 mM) of alphaxalone to potentiate responses to glycine was con®rmed in the present study, although previous investigations performed on the rat cuneate slice 21 and optic nerve preparations, 11 mouse spinal neurones in culture 22 and Xenopus laevis oocytes 23 expressing hetero-oligomeric a 1 b glycine receptors did not detect such an action. This apparent discrepancy could be explained by the fact that the present study used a maximal concentration of alphaxalone higher than that previously examined, or by differences in glycine receptor subunit composition between studies. The latter is known to in¯uence the actions of certain steroids upon glycine receptors. 20 In this study, we also detected limited enhancement of responses to glycine by 5a-pregnan-3a-ol-20-one, but the magnitude of this effect was approximately 20-fold less than the maximal enhancement of currents mediated by the a 1 b 2 g 2L GABA A receptor isoform, 14 perhaps contributing to the perception that this steroid is essentially`inactive' at the glycine receptor. 17 24 Nonetheless, the EC 50 value (250 nM) for 5a-pregnan-3a-ol-20-one at the a 1 glycine receptor is only 1.5-fold higher than that reported for the a 1 b 2 g 2L GABA A receptor isoform (i.e. 177 nM). 14 Structurally, minaxolone, Org 20599, alphaxalone and 5a-pregnan-3a-ol-20-one share a pregnane ring backbone presenting a hydroxyl group at C3 in the a-con®guration (i.e. projecting below the surface of the steroid ring), an A and B ring fusion in the trans orientation and a keto group at C20 of the acetyl side chain, Fig. 1) . Alphaxalone, containing an 11-keto substituent (Fig. 1) , appears 100-fold less potent (EC 50 = 27.8 mM) than 5a-pregnan-3a-ol-20-one at the glycine a1 receptor, but displays an enhanced maximal effect (Table 1) . Additional C21-chloro-and 2b-morpholinyl-substituents in the structure of alphaxalone (i.e. Org 20599) have no effect upon potency (EC 50 =22.9 mM), but increase maximal enhancement of the glycine evoked current (Table 1) . Minaxolone, containing 2b-ethoxy and 11a-dimethyl amino substituents (Fig. 1) , is both more potent (EC 50 =13.1 mM) and ef®cacious than any of the other substituted steroids derived from 5a-pregnan3a-ol-20-one (Table 1) . It would be of interest to explore the individual contributions of the 2b-ethoxy and 11a-dimethyl groups upon activity at the glycine receptor, particularly because the 2b-ethoxy substituent confers superior anaesthetic potency over alphaxalone, 25 but unfortunately such compounds are not currently available.
The effect of substituents at C2 and C11 upon activity at the a 1 glycine receptor is distinct from that observed for GABA A receptor isoforms because at the latter alphaxalone, ORG 20599 and minaxolone exert maximal effects comparable to 5a-pregnan-3a-ol-20-one, albeit with slightly reduced potency ( Table 1) . The difference in the steroid structure±activity relationship at GABA A and glycine receptors was emphasized by comparing the effects of the diasteromers 5a-pregnan-3a-ol-20-one, 5b-pregnan-3a-ol-20-one, 5a-pregnan-3b-ol-20-one and 5b-pregnan-3b-ol-20-one (Fig. 1) . In contrast to the modest potentiation observed for 5a-pregnan-3a-ol-20-one, 5b-pregnan-3a-ol-20-one inhibited the response to glycine in a concentrationdependent manner. At native 15 16 and recombinant GABA A receptor isoforms, this pair of diastereomers exhibits approximately equal potency and ef®cacy in potentiating the actions of GABA. These observations indicate that the con®guration of the pregnane steroid A and B ring fusion is a determinant of activity at the a 1 glycine receptor, the trans-and cis-conformations favouring potentiation and inhibition respectively. The 3b-epimers of the 5a-and 5b-pregnanes were both inactive upon either a 1 glycine receptors or GABA A receptors assembled from a 1 , b 2 and g 2L subunits, demonstrating that, for either inhibitory receptor, activity is suppressed if the C3-hydroxyl projects above the plane of the pregnane ring system.
Previous studies of steroidal regulation of the glycine receptors native to spinal neurones and the recombinant a 1 receptor have reported predominantly inhibitory effects, as found here for 5b-pregnan-3a-ol-20-one. Steroids causing inhibition include: pregnenolone (5a-pregnen-3b-ol-20-one) hemisuccinate, 20 pregnenolone sulphate, 17 20 dehydroepiandrosterone (5-androsten-3b-ol-17-one) sulphate, 20 5a-androstan-3b-ol-17-one sulphate, 20 progesterone, 17 17a-OH-progesterone, 17 deoxycorticosterone 17 and corticosterone. 17 The more potent of these compounds (K i =1.9 to 9.8 mM) all possess a negative charge at C3, provided by a substituted sulphate or hemisuccinate group, which Maksay and collegues 20 postulate to be important for inhibition of the a 1 glycine receptor. The lower potency of C3-hydroxylated 5a-pregnan-3b-ol-20-one found in the present study is in agreement with this suggestion. However, both 5a-androstan-3b-ol-17-one sulphate and 5a-androstan-3a-ol-17-one sulphate inhibit the a 1 glycine receptor with similar potency and effectiveness, 20 indicating that the orientation of the androstane A and B rings is not a determinant of action of the sulphated steroids.
In contrast to the potentiation of the extracellularly recorded response to glycine obtained with the rat optic nerve preparation, 11 the glucocorticosteroids 20a-dihydrocortisol, a-cortol and hydrocortisone had no detectable effect upon current responses to glycine mediated by the a 1 glycine receptor. It is possible that differences in glycine receptor subunit composition may contribute to such a discrepancy, as may the difference in the electrophysiological techniques employed. Nonetheless, the present results are in agreement with data obtained from chick spinal neurones, where responses to glycine were similarly insensitive to hydrocortisone and weakly depressed, rather than potentiated, by corticosterone and deoxycorticosterone. 17 There is abundant evidence to support the notion that the GABA A receptor is a major molecular target of general anaesthetic action, 3±7 26 but a similar role for the glycine receptor is less certain. Many classes of experimental and clinical anaesthetics including gases, alcohols, some barbiturates, propofol, etomidate and volatile agents in particular, potentiate responses to glycine, but this is not a universal feature of anaesthetic action at the molecular level. 2±5 8 26 27 In addition, the concentrations of anaesthetic required to positively modulate the glycine receptor are, for intravenous agents at least, considerably higher than those required for an equivalent effect at the GABA A receptor and frequently lie outside the clinically relevant range. 24 The present study demonstrates that modulation of glycine receptor activity by steroids is not crucial to their anaesthetic activity because the isomers 5a-pregnan-3a-ol-20-one and 5b-pregnan-3a-ol-20-one, both of which are general anaesthetics, produced opposing effects upon glycine receptor function. This, however, does not preclude a contribution to anaesthesia that may be agent speci®c. Amongst intravenous anaesthetics, minaxolone emerges as a relatively potent and ef®cacious positive allosteric modulator of glycine receptor function. The free-plasma concentration of minaxolone that abolishes movement in response to a noxious stimulus has been estimated to be approximately 200 nM, after correction for extensive protein binding of 95%. 28 Although dif®cult to interpret due the disposition and biophase concentrations of the anaesthetic being unknown, such a value provides an approximate guide to the concentrations of minaxolone that might be clinically relevant. The EC 50 values for potentiation of GABA and glycine receptor activity by minaxolone of 1.3 and 13 mM respectively would thus suggest the potential for modulation of synaptic transmission mediated by GABA, but not glycine, in vivo. However, as a caveat, it should be noted that receptors expressed heterologously in Xenopus oocytes might not be subject to the same post-translational modi®cations, such as phosphorylation, as occur in their native, neuronal, environment. Phosphorylation of GABA A receptor isoforms by protein kinase C, for example, is known to enhance sensitivity to neurosteroids in the hippocampal dentate gyrus. 29 Hence, extrapolations from relatively simple in vitro systems to the situation in vivo must be made with caution.
Agents that potentiate glycinergic neurotransmission are of interest because glycine has a pivotal role in the processing of sensory input at the spinal level and is known to suppress nociceptive signals. 2 The importance of glycerinergic neurotransmission is vividly illustrated by numerous mutations of the glycine receptor a 1 subunit that are associated with hyperekplexia, an autosomal dominant disorder in which reduced postsynaptic sensitivity to glycine underlies an exaggerated startle re¯ex and neonatal hypertonia. 30 Although currently best managed by the benzodiazepine, clonazepam, presumably via compensatory facilitation of GABA-ergic neurotransmission, agents that enhance the actions of glycine would be a logical treatment for this condition. More generally, potentiation of glycine receptor function within the spinal cord can be anticipated to produce analgesia. 2 Anaesthetics that combine the ability to potentiate both GABA-ergic and glycinergic transmission might thus be of considerable utility.
